Spanish Red Biotech Pipeline

Amgen

apremilast

Type: Biodrugs/ Drugs
Therapeutic area: Autoimmune & Inflammation
Indication: Subjects with active Behçet's disease
Phase: 3Phase III in Spain, 2Phase II in Spain, 1Phase I in Spain